Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Menopause remedy sales

This article was originally published in The Tan Sheet

Executive Summary

Drugstore.com sales of supplements for menopause symptoms during third week of July jumped 47% over average weekly sales for the year, company says in first edition of the Health & Beauty Index. Increase followed release of Women's Health Initiative findings questioning safety of hormone replacement therapies, and supplement makers have since stepped up PR efforts touting their products as HRT alternatives (1"The Tan Sheet" July 29, 2002, In Brief). July sales on drugstore.com of GSK's Remifemin jumped 46% from June levels; other top-selling brands included J&J Personal Products' Healthy Woman, Pharmavite's Nature's Resource Soy Balance. E-tailer's new monthly index measures U.S. population trends, attitudes through health and wellness purchases...

You may also be interested in...



HRT vs. supplements

Dietary Supplement Education Alliance is spending "in the five figures" to develop video news release (VNR) promoting supplement ingredients as alternatives to hormone replacement therapy for menopausal symptoms. Slated for release in early to mid August, the VNR will be accessible by every TV station in U.S. for possible inclusion in local news health segments. Two- to three-minute feature will include interviews with two Los Angeles-based doctors. Supplement marketers also are stepping up PR efforts following studies raising concerns about safety of long-term HRT use. GlaxoSmithKline (Remifemin) reps are now calling on family practitioners as well as OB/GYNs. Novogen is alerting independent pharmacists about safety, efficacy of its Promensil supplement, while Rexall (Sundown Menopause Support) is planning additional in-store promotions that may reference articles on HRT studies...

Stockwatch: The Pandemic – Where Generics Failed To Reign

If demand-side pressures on the life science sector were not enough, generic price erosion, debt repayment and extended restructurings are worsening the generic pharmaceutical investment proposition.

QUOTED. 1 March 2021. Xavier Becerra.

California state Attorney General Xavier Becerra promised during two US Senate committee hearings that, if confirmed as Secretary of Health and Human Services, he will let science shape HHS policy.

Topics

UsernamePublicRestriction

Register

OM004078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel